Philips Enters New Agreement on Patient Monitoring Systems and Software with the Stockholm County Council

PhilipsRoyal Philips (NYSE: PHG; AEX: PHIA) today announced that it has signed a new agreement with the Stockholm County Council on patient monitoring systems and software for the Karolinska University Hospital, which comprises the New Karolinska Solna University Hospital and the Karolinska University Hospital Huddinge.

As part of the agreement, Philips will deliver patient monitoring systems and clinical decision support applications that can be used to monitor a patient's vital signs including the respiratory rate, pulse, blood pressure and temperature.

"The deterioration of a patient's condition is often preceded by physiological changes that can be detected up to 24 hours before a serious event," said Håkan Skytt, Customer Manager at Philips Sweden. "Changes in a patient's vital signs are frequently an indication that the patient's condition is worsening and that there is an increased risk of complications. Constant monitoring of the vital signs will allow any subtle changes to be detected and addressed in a timely manner."

The new agreement further includes an innovation collaboration to jointly develop next-generation solutions for patient-centric care.

"For Philips, strategic partnerships with leading healthcare providers such as Karolinka University Hospital are an important and effective way to create innovative health technologies that can both streamline and enhance the delivery of care," said Johan Folkunger, General Manager of Philips' Health Systems businesses in Sweden.

Philips' patient monitoring systems can measure and collect a patient's vital signs and allow remote monitoring from a central workstation as well as bedside monitoring at an individual patient's bedside. The data can be readily accessed and used by the relevant staff for the adequate delivery of care. The collected data is stored centrally at the Karolinska University Hospital and can be used for the delivery of care, quality enhancement and clinical research.

The New Karolinska Solna University Hospital is currently being constructed and will be admitting the first patients in the fourth quarter of 2016. The majority of the construction work is expected to be finalized in the course of 2017 and the hospital is planned to be fully operational in 2018. Karolinska University Hospital is one of the world’s leading academic hospitals, and its new site will reinforce its position in the field of highly specialized medical care.

The New Karolinska Solna University Hospital will implement a patient-centric approach to healthcare and deploy care pathways in which patient care, clinical research and training have been integrated. This is fully in line with Philips' mission to develop meaningful innovations that make a difference for consumers, patients and healthcare providers.

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2015 sales of EUR 24.2 billion and employs approximately 104,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

Zebra Announces Regulatory Approval of i…

Zebra Medical Vision, the leading machine learning imaging analytics company, announces that the company has been granted the CE approval and subsequent release of its Deep Learning Analytics Engine in...

Mind-Controlled Device Helps Stroke Pati…

Stroke patients who learned to use their minds to open and close a device fitted over their paralyzed hands gained some control over their hands, according to a new study...

Philips and Illumina Team Up with Navica…

Royal Philips (NYSE: PHG, AEX: PHIA) and Navican, an Intermountain Healthcare company, today signed an agreement to deploy a precision health informatics solution that will allow hospitals and health systems...

Artificial Intelligence to Assist in the…

The University of Tampere and TAYS (Tampere University Hospital) Heart Hospital use artificial intelligence (A.I.) technologies developed by VTT Technical Research Centre of Finland in the home care of heart...

Boehringer Ingelheim Builds Digital Lab …

With the founding of BI X as independent subsidiary Boehringer Ingelheim will focus on breakthrough innovative digital solutions in healthcare from idea to pilot. The start-up will work closely together...

NHS Organisations to Access IMS MAXIMS C…

Award-winning electronic patient record (EPR) provider IMS MAXIMS has announced the availability of its cloud services on the latest iteration of the UK Government's G Cloud Framework. NHS organisations looking...

Anyone can Become More Curious. Is that …

Merck, a leading science and technology company, today announced the start of an experiment entitled "Anyone can become more curious". Driven by the company’s curiosity initiative, which measured and described...

EC Open Call FETOPEN-01-2016-2017: FET-O…

The successful exploration of new foundations for radically new future technologies requires supporting a large set of early stage, high risk visionary science and technology projects to investigate new ideas...

Home Monitoring of Blood Sugar Did Not I…

Self-monitoring of blood glucose levels in patients with type 2 diabetes who are not treated with insulin did not improve glycemic control or health-related quality of life after one year...

Call for Applications: 2017 Lyfebulb-Nov…

For the second year in a row, Lyfebulb and Novo Nordisk will support international patient entrepreneurs who develop innovative ideas and concepts aimed to positively empower and impact the lives...

New Cellular Imaging Paves Way for Cance…

Researchers at the Universities of York and Leiden have pioneered a technique which uses florescent imaging to track the actions of key enzymes in cancer, genetic disorders and kidney disease...

Bayer Grants4Apps® Dealmaker Berlin 2017

Bayer Grants4Apps® is calling all mature teams, startups and companies that have a solution ready to go. The new Dealmaker is all about quality facetime between you and Grants4Apps' experts...